Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rinvoq 30mg modified-release tablets
1001030AEBBABAB
|
Rinvoq | Upadacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Rinvoq 45mg modified-release tablets
1001030AEBBACAC
|
Rinvoq | Upadacitinib | Musculoskeletal and Joint Diseases | No data available |
|
Riociguat 1.5mg tablets
0205010ABAAACAC
|
Riociguat | Riociguat | Cardiovascular System | No data available |
|
Riociguat 1mg tablets
0205010ABAAABAB
|
Riociguat | Riociguat | Cardiovascular System | No data available |
|
Riociguat 2.5mg tablets
0205010ABAAAEAE
|
Riociguat | Riociguat | Cardiovascular System | No data available |
|
Riociguat 2mg tablets
0205010ABAAADAD
|
Riociguat | Riociguat | Cardiovascular System | No data available |
|
Riociguat 500microgram tablets
0205010ABAAAAAA
|
Riociguat | Riociguat | Cardiovascular System | No data available |
|
Risankizumab 360mg/2.4ml solution for injection cartridges
0105030C0AAAAAA
|
Risankizumab | Risankizumab | Gastro-Intestinal System | No data available |
|
Risankizumab 75mg/0.83ml inj pre-filled syringes
1305030I0AAAAAA
|
Risankizumab | Risankizumab | Skin | No data available |
|
Risedronate sodium 35mg/5ml oral liquid
0606020R0AAAEAE
|
Risedronate sodium | Risedronate sodium | Endocrine System | No data available |
|
Risperdal Quicklet 1mg orodispersible tablets
040201030BBAHAL
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 2mg orodispersible tablets
040201030BBAIAM
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 3mg orodispersible tablets
040201030BBAKAP
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 4mg orodispersible tablets
040201030BBALAQ
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Risperdal Quicklet 500microgram orodispersible tablets
040201030BBAJAN
|
Risperdal | Risperidone | Central Nervous System | No data available |
|
Ritalmex 200mg capsules
0203020P0BDAAAN
|
Ritalmex | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Rite-Diet gluten free fibre bread sliced
0904010H0BEABAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free fibre bread unsliced
0904010H0BEAEAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free fibre mix
090401030BDAFAK
|
Rite-diet (g/f mix) | Gluten free mixes | Nutrition and Blood | No data available |
|
Rite-Diet gluten free fibre rolls
0904010H0BEADAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked fibre loaf
0904010H0BEAIAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked long fibre rolls
0904010H0BEAJAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked long white rolls
0904010H0BEAHAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked white loaf
0904010H0BEAGAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free white bread sliced
0904010H0BEAAAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.